Adaptimmune Therapeutics plc (Nasdaq: ADAP) announced a succession plan for the Chairmanship position that will take effect at the end ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE